• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

器官移植后儿童的皮肤癌

Skin cancer in children after organ transplantation.

作者信息

Imko-Walczuk Beata, Roskosz-Stożkowska Magdalena, Szymańska Katarzyna, Kadylak Damian, Dębska-Ślizień Alicja

机构信息

Dermatology and STD Outpatient Clinic, Copernicus Medical Centre, Gdansk, Poland.

Department of Dermatology, Copernicus Medical Centre, Gdansk, Poland.

出版信息

Postepy Dermatol Alergol. 2019 Dec;36(6):649-654. doi: 10.5114/ada.2019.82680. Epub 2019 Dec 30.

DOI:10.5114/ada.2019.82680
PMID:31997989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6986283/
Abstract

Skin cancer is the second most common complication of organ transplantation in children. The frequency of skin cancer incidence after organ transplantation is different in paediatric and adult populations. The post-transplant lymphoproliferative disease is the most common group of malignancies after organ transplantation in paediatric population. The majority of researchers who examined children with kidney, liver, heart or lungs grafts observed that the risk of skin cancer was three times higher than in the general population whereas in adults even200 times higher. The occurrence of skin cancer in children after transplantation is extremely rare during childhood. The risk increases in early adulthood. Malignancies occurring after solid organ transplantation result from many different factors. These include the immunological condition of the child, dose and time of immunosuppression, and oncogenic viruses. The increased risk of skin cancer following paediatric transplantation requires prevention and adequate education of children and their parents. These involve avoiding sun exposure and protection such as sunscreens and protective clothing. The early detection of cancer in transplant recipients is very important. Prevention of cancer includes regular dermatological examination.

摘要

皮肤癌是儿童器官移植的第二大常见并发症。儿童和成人器官移植后皮肤癌的发病率有所不同。移植后淋巴组织增生性疾病是儿童器官移植后最常见的恶性肿瘤类型。大多数研究肾脏、肝脏、心脏或肺移植儿童的研究人员发现,儿童皮肤癌的风险比普通人群高3倍,而在成人中甚至高200倍。儿童移植后皮肤癌在儿童期极为罕见。成年早期风险增加。实体器官移植后发生的恶性肿瘤由许多不同因素导致。这些因素包括儿童的免疫状况、免疫抑制的剂量和时间以及致癌病毒。儿童移植后皮肤癌风险增加需要对儿童及其父母进行预防和充分教育。这些措施包括避免阳光照射以及使用防晒霜和防护服等防护措施。移植受者癌症的早期检测非常重要。癌症预防包括定期进行皮肤科检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc4/6986283/e9a139e5c543/PDIA-36-82680-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc4/6986283/1f077aa861dd/PDIA-36-82680-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc4/6986283/e9a139e5c543/PDIA-36-82680-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc4/6986283/1f077aa861dd/PDIA-36-82680-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbc4/6986283/e9a139e5c543/PDIA-36-82680-g002.jpg

相似文献

1
Skin cancer in children after organ transplantation.器官移植后儿童的皮肤癌
Postepy Dermatol Alergol. 2019 Dec;36(6):649-654. doi: 10.5114/ada.2019.82680. Epub 2019 Dec 30.
2
Skin Cancer Risk Awareness and Sun-Protective Behavior Among Solid-Organ Transplant Recipients.实体器官移植受者的皮肤癌风险意识与防晒行为
Exp Clin Transplant. 2018 Mar;16 Suppl 1(Suppl 1):203-207. doi: 10.6002/ect.TOND-TDTD2017.P65.
3
Skin surveillance of a U.K. paediatric transplant population.对英国儿科移植人群的皮肤监测。
Br J Dermatol. 2007 Jan;156(1):45-50. doi: 10.1111/j.1365-2133.2006.07546.x.
4
Post-transplant malignancies in pediatric organ transplant recipients.小儿器官移植受者的移植后恶性肿瘤
Pediatr Transplant. 2021 Feb;25(1):e13884. doi: 10.1111/petr.13884. Epub 2020 Oct 27.
5
Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment.器官移植患者的上皮性恶性肿瘤:临床表现与新治疗方法
Recent Results Cancer Res. 2002;160:251-8. doi: 10.1007/978-3-642-59410-6_30.
6
Skin cancers following pediatric organ transplantation.小儿器官移植后的皮肤癌
Dermatol Surg. 2004 Apr;30(4 Pt 2):616-21. doi: 10.1111/j.1524-4725.2004.30146.x.
7
Malignancies after pediatric solid organ transplantation.儿童实体器官移植后的恶性肿瘤。
Pediatr Nephrol. 2021 Aug;36(8):2279-2291. doi: 10.1007/s00467-020-04790-2. Epub 2020 Oct 15.
8
Malignancy incidence after renal transplantation in children: a 20-year single-centre experience.儿童肾移植后恶性肿瘤的发病情况:20 年单中心经验。
Nephrol Dial Transplant. 2010 Feb;25(2):611-6. doi: 10.1093/ndt/gfp497. Epub 2009 Oct 10.
9
Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.单中心674例实体器官移植受者的移植后恶性肿瘤发病率。
Clin Transplant. 1996 Jun;10(3):248-55.
10
malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature.肝移植后的恶性肿瘤:免疫抑制的影响——个人数据和文献回顾。
World J Gastroenterol. 2019 Sep 21;25(35):5356-5375. doi: 10.3748/wjg.v25.i35.5356.

引用本文的文献

1
Targeting Calcineurin Inhibitor-Induced Arterial Hypertension in Liver Transplanted Children Using Hydrochlorothiazide.使用氢氯噻嗪治疗肝移植儿童中钙调神经磷酸酶抑制剂诱导的动脉高血压
J Pediatr Pharmacol Ther. 2022;27(5):428-435. doi: 10.5863/1551-6776-27.5.428. Epub 2022 Jul 6.
2
The Aquaporin3 Promoter Polymorphism -1431 A/G is Associated with Acute Graft Rejection and Cytomegalovirus Infection in Kidney Recipients Due to Altered Immune Cell Migration.水通道蛋白 3 启动子多态性-1431 A/G 与急性移植物排斥和巨细胞病毒感染相关,这是由于免疫细胞迁移改变所致。
Cells. 2020 Jun 8;9(6):1421. doi: 10.3390/cells9061421.

本文引用的文献

1
Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients.依维莫司与霉酚酸酯方案用于小儿肾移植受者的疗效和安全性比较
PLoS One. 2015 Sep 25;10(9):e0135439. doi: 10.1371/journal.pone.0135439. eCollection 2015.
2
Three-yr safety and efficacy of everolimus and low-dose cyclosporine in de novo pediatric kidney transplant patients.依维莫司与低剂量环孢素用于初发小儿肾移植患者的3年安全性与疗效
Pediatr Transplant. 2014 Jun;18(4):350-6. doi: 10.1111/petr.12261.
3
Spectrum of cancer risk among US solid organ transplant recipients.
美国实体器官移植受者的癌症风险谱。
JAMA. 2011 Nov 2;306(17):1891-901. doi: 10.1001/jama.2011.1592.
4
Pediatric organ transplantation and risk of premalignant and malignant tumors in Sweden.瑞典儿科器官移植与癌前和恶性肿瘤风险。
Am J Transplant. 2011 Jan;11(1):146-51. doi: 10.1111/j.1600-6143.2010.03367.x.
5
Malignancy incidence after renal transplantation in children: a 20-year single-centre experience.儿童肾移植后恶性肿瘤的发病情况:20 年单中心经验。
Nephrol Dial Transplant. 2010 Feb;25(2):611-6. doi: 10.1093/ndt/gfp497. Epub 2009 Oct 10.
6
Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients.识别肾移植后癌症的高危人群并量化绝对风险:一项针对15183名受者的队列研究。
Am J Transplant. 2007 Sep;7(9):2140-51. doi: 10.1111/j.1600-6143.2007.01908.x. Epub 2007 Jul 19.
7
Clinical and dermatoscopic fading of post-transplant eruptive melanocytic nevi after suspension of immunosuppressive therapy.免疫抑制治疗中断后移植后爆发性黑素细胞痣的临床及皮肤镜消退情况
J Am Acad Dermatol. 2006 Feb;54(2):338-40. doi: 10.1016/j.jaad.2005.06.023.
8
Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies.使用雷帕霉素靶蛋白抑制剂进行维持性免疫抑制与新发恶性肿瘤发病率降低相关。
Transplantation. 2005 Oct 15;80(7):883-9. doi: 10.1097/01.tp.0000184006.43152.8d.
9
Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation.肾移植中多克隆抗体诱导后发生移植后淋巴细胞增殖性疾病的风险。
Pediatr Transplant. 2005 Oct;9(5):622-6. doi: 10.1111/j.1399-3046.2005.00361.x.
10
Posttransplant malignancy.移植后恶性肿瘤
Prog Transplant. 2004 Sep;14(3):193-200. doi: 10.1177/152692480401400304.